Showing results (41-50 of 134) with videos related to
Sort By:
Pageof 14
JAMA Network Open|June 2, 2022
Data Sharing and Reanalyses Among Randomized Clinical Trials Published in Surgical Journals Before and After Adoption of a Data Availability and Reproducibility PolicyDamien Bergeat, Nicolas Lombard, Anis Gasmi, et al.Plos One|August 21, 2020
Funders' data-sharing policies in therapeutic research: A survey of commercial and non-commercial fundersJeanne Fabiola Gaba, Maximilian Siebert, Alain Dupuy, et al.Medicine|June 17, 2016
Mortality, cardiovascular risk, and androgen deprivation therapy for prostate cancer: A systematic review with direct and network meta-analyses of randomized controlled trials and observational studiesLucie-Marie Scailteux, Florian Naudet, Quentin Alimi, et al.Clinical Trials (London, England)|April 7, 2026
Evidence supporting European Medicines Agency drug approvals (2020-2023): A cross-sectional study of trial design and outcomesMaximilian Siebert, Laura Caquelin, Florian Naudet, et al.BMJ Open|August 9, 2023
Are large prospective trials on antidepressants in mental disorders seeding trials? A descriptive study of trials registered on ClinicalTrials.govSamuel Martineau, Ioana-Alina Cristea, Astrid Chevance, et al.Systematic Reviews|April 16, 2022
Tolerability of duloxetine in elderly and in non-elderly adults: a protocol of a systematic review and individual participant data meta-analysis of randomized placebo-controlled trialsJean-Charles Roy, Chloé Rousseau, Alexis Jutel, et al.European Archives of Psychiatry and Clinical Neuroscience|June 23, 2017
Is electroconvulsive therapy an evidence-based treatment for catatonia? A systematic review and meta-analysisArnaud Leroy, Florian Naudet, Guillaume Vaiva, et al.Alcohol and Alcoholism (Oxford, Oxfordshire)|October 22, 2020
French Validation of the Alcohol Urge Questionnaire: Psychometric Properties and Relationship with Alcohol Dependence and Drinking BehaviorAymery Constant, Marlene Sanz, Manon Auffret, et al.Plos Medicine|August 9, 2021
An open science pathway for drug marketing authorization-Registered drug approvalFlorian Naudet, Maximilian Siebert, Rémy Boussageon, et al.BMJ Medicine|March 20, 2023
Vibration of effect in more than 16 000 pooled analyses of individual participant data from 12 randomised controlled trials comparing canagliflozin and placebo for type 2 diabetes mellitus: multiverse analysisHenri Gouraud, Joshua D Wallach, Rémy Boussageon, et al.Pageof 14